Sagimet Biosciences (NasdaqGM:SGMT) 2026 Conference Transcript

Sagimet Biosciences (NasdaqGM:SGMT) 2026 Conference February 11, 2026 10:00 AM ET Company ParticipantsDavid Happel - CEOEduardo Martins - Chief Medical OfficerRobert D’Urso - SVP of New ProductsConference Call ParticipantsSeamus Fernandez - Senior Managing Director and Senior AnalystSeamus FernandezThanks for joining us here at Guggenheim's Emerging Outlook Conference. This is our biotech summit for 2026. We've hosted this event annually for several years now, but really excited to have Sagimet join us here ...